IN2014KN00796A - - Google Patents

Info

Publication number
IN2014KN00796A
IN2014KN00796A IN796KON2014A IN2014KN00796A IN 2014KN00796 A IN2014KN00796 A IN 2014KN00796A IN 796KON2014 A IN796KON2014 A IN 796KON2014A IN 2014KN00796 A IN2014KN00796 A IN 2014KN00796A
Authority
IN
India
Prior art keywords
cancer
combinations
oleanderthis
neriumnerium
cisplatin
Prior art date
Application number
Other languages
English (en)
Inventor
Dennis R Knocke
Joseph B Nester
Ioannis Papasotiriou
Original Assignee
Nerium Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerium Biotechnology Inc filed Critical Nerium Biotechnology Inc
Publication of IN2014KN00796A publication Critical patent/IN2014KN00796A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IN796KON2014 2011-10-20 2012-10-20 IN2014KN00796A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161549386P 2011-10-20 2011-10-20
PCT/US2012/061226 WO2013059753A1 (en) 2011-10-20 2012-10-20 Therapeutic combination for the treatment of cancer

Publications (1)

Publication Number Publication Date
IN2014KN00796A true IN2014KN00796A (es) 2015-10-02

Family

ID=48141445

Family Applications (1)

Application Number Title Priority Date Filing Date
IN796KON2014 IN2014KN00796A (es) 2011-10-20 2012-10-20

Country Status (13)

Country Link
US (2) US20130209579A1 (es)
EP (2) EP3711754A1 (es)
JP (1) JP6255346B2 (es)
CN (2) CN104093405A (es)
AU (3) AU2012325819B2 (es)
BR (1) BR112014009421A2 (es)
CA (1) CA2852274C (es)
GT (1) GT201400071A (es)
IL (2) IL231987B (es)
IN (1) IN2014KN00796A (es)
MX (2) MX365635B (es)
RU (2) RU2017136415A (es)
WO (1) WO2013059753A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102186487B (zh) * 2008-10-14 2013-05-15 奈瑞姆生物技术公司 提取强心苷的方法和组合物
AU2016250616B2 (en) * 2015-04-22 2021-01-21 Syn-Nat Products Enterprise LLC Co-crystal composition and its pharmaceutical use
KR20180063075A (ko) * 2015-10-05 2018-06-11 뉴카나 피엘씨 조합 요법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK239687A (da) 1986-05-13 1987-11-14 Huseyin Ziya Ozel Planteekstrakter
CA2354037A1 (en) 1998-09-24 2000-03-30 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20060205679A1 (en) * 2004-10-22 2006-09-14 Azaya Therapeutics, Inc. Topical and oral formulations of cardiac glycosides for treating skin diseases
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (en) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutic use of an extract from the leaves of Nerium oleander
DK2173337T3 (da) 2007-08-06 2014-09-15 Univ Ohio Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin
CN102186487B (zh) * 2008-10-14 2013-05-15 奈瑞姆生物技术公司 提取强心苷的方法和组合物

Also Published As

Publication number Publication date
WO2013059753A1 (en) 2013-04-25
AU2012325819B2 (en) 2017-08-03
CN110269940A (zh) 2019-09-24
JP6255346B2 (ja) 2017-12-27
NZ623550A (en) 2016-06-24
CA2852274C (en) 2019-08-06
JP2014530878A (ja) 2014-11-20
IL231987B (en) 2020-07-30
EP2768498B1 (en) 2020-03-04
CN104093405A (zh) 2014-10-08
AU2019203577A1 (en) 2019-06-13
BR112014009421A2 (pt) 2017-04-18
MX365635B (es) 2019-06-10
IL275636A (en) 2020-08-31
RU2014120179A (ru) 2015-11-27
EP3711754A1 (en) 2020-09-23
MX2019006685A (es) 2019-08-21
US20130209579A1 (en) 2013-08-15
EP2768498A1 (en) 2014-08-27
RU2017136415A3 (es) 2021-02-08
AU2017254875A1 (en) 2017-11-23
GT201400071A (es) 2015-09-17
CA2852274A1 (en) 2013-04-25
RU2017136415A (ru) 2019-02-08
US20190343908A1 (en) 2019-11-14
AU2012325819A1 (en) 2014-04-24
IL231987A0 (en) 2014-05-28
EP2768498A4 (en) 2015-06-17
MX2014004527A (es) 2014-09-15

Similar Documents

Publication Publication Date Title
PH12015501744B1 (en) Therapeutic and diagnostic target for cancer comprising dll3 binding reagents
MX360404B (es) Compuestos para inhibir la proliferacion celular en canceres transmitidos por egfr.
SA515360657B1 (ar) مثبطات ديميثيلاز هيستون
EA201290901A1 (ru) Фитоканнабиноиды для лечения злокачественной опухоли
MX2016002051A (es) Metodos y kits para la subtipificacion molecular de tumores.
MX366804B (es) Translocaciones de la r-espondina y sus metodos de uso.
MX2013002084A (es) Biomarcadores y metodos de tratamiento.
MX2015007185A (es) Uso de eribulina en el tratamiento de cancer de pecho.
MX2014009751A (es) Anticuerpos contra integrina alfavhbeta6 y uso de los mismos para tratar cancer.
MX2016004678A (es) Composiciones para el tratamiento del cancer.
EA201692483A1 (ru) Ингибиторы гистоновой метилазы
MA33973B1 (fr) Méthodes de traitement du cancer à l'aide d'antagonistes de notch
MX2015014046A (es) Combinaciones de farmacos para tratar cancer.
MX336761B (es) Compuestos para el tratamiento de cancer.
MX2019006331A (es) Métodos para tratar el cáncer usando anticuerpos anti-pd-l1 y antiandrógenos.
EA201370071A1 (ru) Способы и композиции для лечения рака легких
MX2013015340A (es) Composiciones y metodos para el tratamiento de cancer.
CR20110479A (es) Combinaciones farmaceuticas que comprenden rdea 119/bay 869766 para el tratamiento de canceres especificos
NZ703411A (en) Use of markers in the diagnosis and treatment of prostate cancer
FR2945210B1 (fr) Combinaison antitumorale comprenant l'ave8062 et le sorafenib
PH12015502757A1 (en) Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
WO2013188750A3 (en) Substituted macrocyclic compounds having proteasome inhibitory activity
WO2013081645A3 (en) Erbb3 mutations in cancer
IN2014KN00796A (es)
GB2490849A (en) Di-asprin derivatives for use in the treatment of colorectal cancer